Member Info for Sheephatch

The agreement will enable Beckman Coulter to sell and distribute GENE’s high-throughput COVID-19 PCR Kit in the US and Europe for use on upper respiratory viral samples.

The partnership is the result of an agreement announced in August 2020, under which the companies worked to develop and validate a fully automated PCR process for Beckman’s Biomek automated workstation in conjunction with its RNAdvance Viral XP extraction kit.

Genedrive has described its SARS-CoV-2 test as ‘ideally suited’ for use on the high throughput robotic Biomek i7 instrument due to its ready-to-go nature of the test.

This removes many of the fluid dispensing steps required in competitor assays, increasing the throughput of the Biomek compared to using a liquid reagent-based test formulation.?

The Company said full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms.

Good strong reassuring news.

Do the math. This is massively undervalued and we could be many multiples from here in just a few weeks. I know people use NCYT as an example and we are not the same. However the company growth potential for us entering the biggest market in the world where mass testing is going to be required likely for years if not lifetimes is much bigger than a few quid. Hold and grow some. Good luck.

SARS-CoV-2 Detection

Assays: Genedrive® 96 SARS-CoV-2 Kit

The Genedrive® 96 SARS-CoV-2 Kit, a novel Polymerase Chain Reaction (PCR) assay designed to detect active SARS-CoV-2 infection in COVID-19 patients, uses a “ready-to-go” solid PCR bead format that eliminates the need for time-consuming and error-prone reagent preparation, a requirement in all other open-platform tests.

Genedrive® 96 SARS-CoV-2 Kit
The kit is intended to use viral RNA samples that have been pre-extracted from specimens such as nasopharyngeal and oropharyngeal swabs, in association with an approved nucleic acid extraction system. The Genedrive® 96 SARS-CoV-2 Kit is intended to be used for the qualitative diagnosis of SARS-CoV-2 infection in symptomatic individuals.

96-well format for high-throughput testing
CE-IVD marked
Simple 1-step process – no reagent preparation errors
End-point PCR – assay time is ~100 minutes
Lyophilized reagents – Ambient storage (2-30°C)
Human RNA control – indicator of sample quality to provide further confidence
High volume manufacturing capabilities – meet global test demands >10,000 tests/hour

Hold the good ones. Very simple.

That is a brilliant idea. The simple things are so often brilliant and just in front of you. Genius who ever thought of that.

Great little RNS.

Kanobo up 276%

I agree this that RNS was an attempt to stop the rise and let certain people get in cheaper before results. The speed of the rise has caught them out.

Would be nice to see this back at 120. Looking better.

Jacks mate says these are going down. Is his mate called Elon, if not I think I think ill take the risk and hold.

I remember someone saying their beard is coming off if this hits a pound by Friday. Great few weeks and months ahead of us here I believe. £1 will be passed very soon.

Cheeky RNS

Thankfully an update. Can’t ask for much more. Not long.

The Dogs do dars. Excellent news and what a massive and long term journey this company has ahead of itself.

Apparently you can now buy a TESLA with Braveheart shares !!!

We need to get Mr Gates on board.

Any of you guys also in PRD. It’s really starting to move. Well worth a look at the three potentials it has.

Welcome to the Dark Side Bigbench. Very different position than GDR but this does have massive possibilities and news could drop at any time. Good luck as always.

The rise this morning is going to bring in new investors who might not have already had us on their radars. It wont take them long to understand the possibilities of a 5 minute test.